This HTML5 document contains 215 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n13http://dx.doi.org/10.1038/
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
n10https://scigraph.springernature.com/pub.10.1038/
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q36775731
rdf:type
wikibase:Item
schema:description
bài báo khoa học 2011年论文 articol științific scientific article published on 5 December 2011 2011年論文 tieteellinen artikkeli vědecký článek 2011年论文 2011年論文 επιστημονικό άρθρο სამეცნიერო სტატია article scientific 2011年論文 мақолаи илмӣ научна статия tudományos cikk مقالة علمية نشرت في 5 ديسمبر 2011 2011年论文 artikulong pang-agham vitskapeleg artikkel artículo científico publicado en 2011 videnskabelig artikel artykuł naukowy wissenschaftlicher Artikel vedecký článok מאמר מדעי artigo científico vitenskapelig artikkel scienca artikolo 2011年論文 artículu científicu espublizáu en 2011 artikel ilmiah vetenskaplig artikel wetenschappelijk artikel 2011年论文 научни чланак scientific article published on 5 December 2011 artigo científico 2011年の論文 ৫ ডিসেম্বর ২০১১-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ научни чланак naučni članak 2011年论文 bilimsel makale artikull shkencor scientific article published on 5 December 2011 2011年論文 2011 թվականի դեկտեմբերի 5-ին հրատարակված գիտական հոդված наукова стаття, опублікована в грудні 2011 teaduslik artikkel 2011 nî lūn-bûn научная статья บทความทางวิทยาศาสตร์ 2011년 논문 article científic 2011年论文 artigo científico article scientifique articolo scientifico
p:P577
wds:Q36775731-44816E5D-8006-4C24-8B81-6B8EE542433A
wdt:P577
2011-12-05T00:00:00Z
p:P407
wds:Q36775731-1189705B-EE47-4369-B806-62A3FFA017DC
wdt:P407
wd:Q1860
p:P2888
wds:Q36775731-20613AE0-0AF4-42D6-A877-13EF515A0A33
wdt:P2888
n10:bmt.2011.181
p:P2860
wds:Q36775731-71BBE6B6-9628-486E-8D9E-704114AA0281 wds:Q36775731-720B166B-EF5F-41AE-9383-858C55735FFF wds:Q36775731-7270C198-AF8A-4296-8C21-499C46FBD7BF wds:Q36775731-7763107A-F47B-4A6F-9E55-6E06DEC6690A wds:Q36775731-6C1791BC-8298-4041-A682-77B9A963172E wds:Q36775731-6D5E7D9A-1547-4F07-A0E5-37B6B815D8F4 wds:Q36775731-7109BAE3-0BE9-420A-AA71-0C0CF0627AF5 wds:Q36775731-63E4BB5B-42DC-4BE9-BAA2-7DE7A421B3B6 wds:Q36775731-64113DFF-B4A7-4C7B-8148-34CA8E3E59B6 wds:Q36775731-6572FCF0-0D7B-421C-B646-08317716C235 wds:Q36775731-6261B6B6-D775-47F9-A3D5-07957C336543 wds:Q36775731-38CE5CB7-7EBA-4062-9F97-5C81E34E0774 wds:Q36775731-3435E4F0-1EFC-449E-B06A-28FEC6317482 wds:Q36775731-35F6FB4C-F35B-4A1F-88EA-FE85424859CB wds:Q36775731-37E17FEE-6805-4DBC-9C94-CCFC3628B6C1 wds:Q36775731-38A37FA3-93ED-419B-B719-5414325061C8 wds:Q36775731-2E845A9D-5C82-4A04-89CD-FB89405408E4 wds:Q36775731-333C139D-3F2C-4687-ADBF-7E704A70C62C wds:Q36775731-33F6F527-F24D-4992-98FC-BE8F0C700954 wds:Q36775731-27292AED-F188-43F4-826B-2CD5B69A10EC wds:Q36775731-27AF5900-9D4F-44CD-B0B8-543E27EB1596 wds:Q36775731-EF311608-9E01-4DD1-A68C-5C948D67A595 wds:Q36775731-EF6609B9-9A79-4046-A9FC-94BEF6F3E807 wds:Q36775731-F5CD1AD9-A156-404D-826E-A8FB3DB6EF22 wds:Q36775731-E46AD883-5E98-463C-81CF-867096B61FBA wds:Q36775731-EB1470A4-D916-430C-AFBB-63952C47CF58 wds:Q36775731-DCB688EE-B10A-46E5-818E-3A64EE17C289 wds:Q36775731-C42C50BD-97A7-4BCE-98B5-1384D98A5EB1 wds:Q36775731-C4A29233-2360-4944-92DC-8561E98C0A69 wds:Q36775731-CBC407AA-769E-4CEC-AB78-74FC20E4234A wds:Q36775731-D3CBA3DF-3DB9-4B27-9808-9BC6EC091D34 wds:Q36775731-B19A31FC-F06F-4055-A4E0-C957FB3A0077 wds:Q36775731-9E183B5C-BE78-45CC-9586-74DE056ED15C wds:Q36775731-A11CC964-AC9C-4A69-8082-D3F195B04A19 wds:Q36775731-A52AF442-95D4-43B1-A1BE-8A45E8263D46 wds:Q36775731-B07351CD-A570-40A6-8358-42752980E45B wds:Q36775731-8FD68219-6DD7-44DC-B4CF-E67BE96CF56B wds:Q36775731-90DC98D5-2760-4475-96E5-A202EA5F5F45 wds:Q36775731-96984D30-CD70-40F2-A703-A1CE6971AF01 wds:Q36775731-7991946C-E81B-426B-8BA8-618E55686204 wds:Q36775731-854C25EA-4BDB-45C9-9FDD-54702A0815BB wds:Q36775731-86704739-14B3-4192-9E6F-E93D1E4289F9 wds:Q36775731-20076C2D-F267-4574-A45C-430828F36335 wds:Q36775731-0CA21353-2B62-4DD4-9C76-B7672AE5FFAB
wdt:P2860
wd:Q33378871 wd:Q33636591 wd:Q47690562 wd:Q37589255 wd:Q37194977 wd:Q84704051 wd:Q34376850 wd:Q79077290 wd:Q78409932 wd:Q78744522 wd:Q37162888 wd:Q36787596 wd:Q43764320 wd:Q47741445 wd:Q33652541 wd:Q25938997 wd:Q40094506 wd:Q29619458 wd:Q33947906 wd:Q41509153 wd:Q71558484 wd:Q41302982 wd:Q58865885 wd:Q29614300 wd:Q37661124 wd:Q35848151 wd:Q41039762 wd:Q33594562 wd:Q84009533 wd:Q39513397 wd:Q37209082 wd:Q33181916 wd:Q35847425 wd:Q43889132 wd:Q35850712 wd:Q33378868 wd:Q73023326 wd:Q58989826 wd:Q33805980 wd:Q48025176 wd:Q81595734 wd:Q44399980 wd:Q53252408 wd:Q46858751
p:P2093
wds:Q36775731-8EEFB45F-B9B5-4ADB-87D1-E64353584556 wds:Q36775731-8F3A6150-D66F-47D2-8A53-72CC067788F6 wds:Q36775731-EF218D33-E57B-486C-8B25-BB5B5A5D22E0 wds:Q36775731-FC921527-DBBD-4696-8782-430910652688 wds:Q36775731-D5122AB8-51CB-49B7-8C4A-14BFF735CFD9 wds:Q36775731-6B35B8FC-5326-4BEB-9D09-7A804DEDA083 wds:Q36775731-5A869D58-6031-4781-BDC2-CD8F7D1A565A wds:Q36775731-537F3944-6049-4604-80B3-FA78DECED29E wds:Q36775731-5564492D-C663-40C9-9029-33299953B801 wds:Q36775731-1361C0FE-2ED8-4C8F-9195-518A8468481A
wdt:P2093
N L Reinsmoen G Broadwater K M Sullivan J P Chute A Clark Y Yang V K Prasad A DeOliveira M E Horwitz D-F Chen
rdfs:label
Differential impact of inhibitory and activating Killer Ig-Like Receptors (KIR) on high-risk patients with myeloid and lymphoid malignancies undergoing reduced intensity transplantation from haploidentical related donors Differential impact of inhibitory and activating Killer Ig-Like Receptors (KIR) on high-risk patients with myeloid and lymphoid malignancies undergoing reduced intensity transplantation from haploidentical related donors Differential impact of inhibitory and activating Killer Ig-Like Receptors (KIR) on high-risk patients with myeloid and lymphoid malignancies undergoing reduced intensity transplantation from haploidentical related donors
skos:prefLabel
Differential impact of inhibitory and activating Killer Ig-Like Receptors (KIR) on high-risk patients with myeloid and lymphoid malignancies undergoing reduced intensity transplantation from haploidentical related donors Differential impact of inhibitory and activating Killer Ig-Like Receptors (KIR) on high-risk patients with myeloid and lymphoid malignancies undergoing reduced intensity transplantation from haploidentical related donors Differential impact of inhibitory and activating Killer Ig-Like Receptors (KIR) on high-risk patients with myeloid and lymphoid malignancies undergoing reduced intensity transplantation from haploidentical related donors
schema:name
Differential impact of inhibitory and activating Killer Ig-Like Receptors (KIR) on high-risk patients with myeloid and lymphoid malignancies undergoing reduced intensity transplantation from haploidentical related donors Differential impact of inhibitory and activating Killer Ig-Like Receptors (KIR) on high-risk patients with myeloid and lymphoid malignancies undergoing reduced intensity transplantation from haploidentical related donors Differential impact of inhibitory and activating Killer Ig-Like Receptors (KIR) on high-risk patients with myeloid and lymphoid malignancies undergoing reduced intensity transplantation from haploidentical related donors
p:P50
wds:Q36775731-30D6ED25-3AEF-49FA-91A7-7FEE3D508444 wds:Q36775731-67A9078E-4549-42CA-A984-60C8D22A3BF5 wds:Q36775731-B7CBDD27-0DCC-4E9A-99E3-79DA5DE3FC8D wds:Q36775731-DBE7C829-27FD-4D96-9E05-D72ACBB15976
wdt:P50
wd:Q110528074 wd:Q88101634 wd:Q92624494 wd:Q110513690
p:P1476
wds:Q36775731-00D8F898-5995-46C0-BE5F-237E77E74DD3
wdt:P1476
Differential impact of inhibitory and activating Killer Ig-Like Receptors (KIR) on high-risk patients with myeloid and lymphoid malignancies undergoing reduced intensity transplantation from haploidentical related donors
p:P304
wds:Q36775731-4D0C480A-62DE-42FC-B953-40DC410F6BBF
wdt:P304
817-823
p:P31
wds:Q36775731-1FD66A97-5957-407A-9D69-F5D7D6766D78
wdt:P31
wd:Q13442814
p:P698
wds:Q36775731-C1F94AD9-442A-4F5A-9A1A-E5DDA87FB6BD
wdtn:P698
n12:22139069
wdt:P698
22139069
p:P1433
wds:Q36775731-3992BA71-10E3-45E9-8D95-F59204031EE8
wdt:P1433
wd:Q4941523
p:P433
wds:Q36775731-233DD5C0-A1B0-45D0-B06F-6CC2C40CA0D0
p:P478
wds:Q36775731-25184E56-EC1E-461D-8620-3436B20C1160
wdt:P433
6
wdt:P478
47
p:P356
wds:Q36775731-DE7332B2-A9AC-443D-A39D-F46950F534F6
wdtn:P356
n13:BMT.2011.181
wdt:P356
10.1038/BMT.2011.181
p:P5875
wds:Q36775731-B4CE064B-FA15-433C-94FD-E6B9E7E4B1CB
wdt:P5875
51851236
p:P6179
wds:Q36775731-DBBFD38E-7032-46F3-BE03-142E646FA02B
wdt:P6179
1010283709
p:P932
wds:Q36775731-2E27292E-59C7-4CC2-BA9E-603361D0DB41
wdt:P932
3629554